medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2022, Number 07

<< Back Next >>

Ginecol Obstet Mex 2022; 90 (07)

Prevalence of the causes of recurrent pregnancy loss in a third-level health care center

Rivera-Chávez Z, Morales-Hernández FV, Godines-Enríquez MS, León DJA

Language: Spanish
References: 22
Page: 559-558
PDF size: 201.57 Kb.


ABSTRACT

Objective: To determine the prevalence of the main etiological factors of recurrent gestational loss in the population of a tertiary care hospital.
Materials and Methods: Retrospective, cross-sectional, descriptive study carried out in patients with study protocol of two or more recurrent gestational losses who initiated prenatal control in the Obstetrics service or who were admitted to the Instituto Nacional de Perinatologia with a diagnosis of infertility between the months of January 2017 to January 2020. In each group, the etiological factors described in the international literature as possible causes of recurrent gestational loss were reviewed.
Results: 280 patients were studied and the factor with the highest prevalence of recurrent gestational loss was endocrine with 56.78% (n = 159), followed by anatomicuterine with 42.14% (n = 118) and thirdly infectious with 40.35% (n = 113). In the 75 patients in the infertility group, the most prevalent etiologic factor was endocrine (88%; n = 66), followed by anatomic-uterine (53.3%; n = 40) and then male (50.6%; n = 38). In patients in the obstetrics group, the factor with the highest prevalence was endocrine (45.36%; n = 93), followed by anatomic-uterine (38.04%; n = 78) and infectious (37%; n = 76).
Conclusions: The factors related to recurrent gestational loss, described in the international literature and analyzed in this study, showed similar prevalences in institutional population. Those that differ are influenced by the characteristics of the population studied, the resources of the institution and, even, the diagnosis and service for which they were admitted as patients to the INPer.


REFERENCES

  1. Malpas P. A Study of abortion sequences. BJOG 1938; 45(6): 932-49. doi:10.1111/j.1471-0528.1938.tb11180.x

  2. Rock JA, Zacur HA. The clinical management of repeatedearly pregnancy wastage. Fertility and Sterility 1983; 39:123-40. doi:10.1016/s0015-0282(16)46809-3

  3. Youssef A, Vermeulen N, Lashley E, Goddijn M, van derHoorn M. Comparison and appraisal of (inter)nationalrecurrent pregnancy loss guidelines. Reprod Biomed Online2019; 39 (3): 497-503. doi:10.1016/j.rbmo.2019.04.008

  4. Bender Atik R, Christiansen O, Elson J, Kolte A, Lewis S,Middeldorp S et al. ESHRE guideline: recurrent pregnancyloss. Human Reproduction Open 2018; 2018 (2). doi:10.1093/hropen/hoy004

  5. Mateo-Sánez HA, Mateo-Sánez E, Hernández-Arroyo L,Rivera-Ramírez P, Mateo-Madrigal M, Mateo-Madrigal V,Mateo-Madrigal D. Pérdida recurrente del embarazo: revisiónbibliográfica. Ginecol Obstet Mex 2016; 84 (8): 523-34.

  6. Manzur YA. Aborto recurrente. Revista Médica ClínicaLas Condes 2010; 21 (3): 416-23. doi: 10.1016/S0716-8640(10)70553-8

  7. Royal College of Obstetricians & Gynaecologists. The investigationand treatment of couples with recurrent first-trimesterand second trimester miscarriage. Guideline No. 17, 2011.

  8. Zhang T, Sun Y, Chen Z, Li T. Traditional and molecular chromosomalabnormality analysis of products of conception inspontaneous and recurrent miscarriage. BJOG 2018; 125:414-20. doi: 10.1111/1471-0528.15052

  9. Homer H. Modern management of recurrent miscarriage.Aust NZJ Obstet Gynecol 2018; 59 (1): 36-44. doi:10.1111/ajo.12920

  10. Amrane S, McConnell R. Endocrine causes of recurrentpregnancy loss. Seminars in Perinatology 2019; 43 (2):80-83. doi:10.1053/j.semperi.2018.12.004

  11. Ke RW. Endocrine basis for recurrent pregnancy loss.Obstet Gynecol Clin 2014; 41:103-12. doi:10.1016/j.ogc.2013.10.003

  12. Hill JA. Recurrent pregnancy loss. In: Kistner's Gynecologyand Women's Health, 7th ed, Ryan KJ, Berkowitz RS,Barbieri RL, Dunaif A (Eds). St. Louis: Mosby, 1999; 396.

  13. Proctor JA, Haney AF. Recurrent first trimester pregnancyloss is associated with uterine septum but not withbicornuate uterus. Fertil Steril 2003; 80 (5): 1212-5. doi:10.1016/S0015-0282(03)01169-5

  14. Homer HA, Li TC, Cooke ID. The septate uterus: A reviewof management and reproductive outcome. Fertil Steril2000; 73 (1): 1-14. doi:10.1016/s0015-0282(99)00480-x

  15. Turocy J, Rackow B. Uterine factor in recurrent pregnancyloss. Seminars in Perinatology 2019; 43 (2): 74-79.doi:10.1053/j.semperi.2018.12.003

  16. Medrano FA, Enríquez MM, Reyes E. Prevalencia de lasalteraciones anatómicas uterinas en mujeres mexicanascon pérdida gestacional recurrente. Gac Med Mex 2016;152: 163-6.

  17. Khalife D, Ghazeeri G, Kutteh W. Review of current guidelinesfor recurrent pregnancy loss: new strategies for optimalevaluation of women who may be superfertile. Seminarsin Perinatology 2019; 43 (2): 105-15. doi:10.1053/j.semperi.2018.12.008.

  18. Quintero-Ronderos P, Laissue P. Genetic variants contributingto early recurrent pregnancy loss etiology identifiedby sequencing approaches. Reproductive Sciences 2019;

  19. 193371911983176. doi:10.1177/193371911983176919. Kutteh WH. Antiphospholipid antibody syndrome and reproduction.Curr Opin Obstet Gynecol 2014; 26 (4): 260-65.doi:10.1097/gco.0000000000000086

  20. Barut M, Bozkurt M, Kahraman M, Yıldırım E, ImirzalioğluN, Kubar A, et al. Thrombophilia and Recurrent PregnancyLoss: The Enigma Continues. Med Sci Monit 2018; 24:4288-94. doi: 10.12659/msm.908832

  21. Ibrahim Y, Johnstone E. The male contribution to recurrentpregnancy loss. Transl Androl Urol 2018; 7 (S3): S317-S327.doi:10.21037/tau.2018.05.14

  22. Tersigni C, D’Ippolito S, Di Nicuolo F, Marana R, ValenzaV, Masciullo V, et al. Correction to: Recurrent pregnancyloss is associated to leaky gut: a novel pathogenic modelof endometrium inflammation? J Transl Med 2019;17(1).doi:10.1186/s12967-019-1823-5




2020     |     www.medigraphic.com